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Hydrolyzable Hemoglobin Adducts of
Polyfunctional Monocyclic N-Substituted
Arenes as Dosimeters of Exposure and Markers
of Metabolism
Iris Zwirner-Baier, Franz-Josef Kordowich, Hans-Gunter Neumann
Institut fur Pharmakologie und Toxikologie der Universitat Wurzburg, Wurzburg, Germany
Hemoglobin adducts of 10 polyfunctional amino- and nitro-substituted benzenes and toluenes were analyzed: 2,4,6-trinitrotoluene, 2,4- and 2,6-dini-
trotoluene, 2-amino-4-nitrotoluene, 4-amino-2-nitrotoluene, 2,4- and 2,6-diaminotoluene, 1,3-dinitrobenzene, 1-amino-3-nitrobenzene, and 1,3-
diaminobenzene. A single dose (0.5 mmole/kg) of the test compounds was administered to female Wistar rats by gavage, and blood extracted and
hemoglobin prepared after 24 hr. One or more cleavage products could be obtained in each case by hydrolyzing hemoglobin (Hb). Hemoglobin binding
indices (HBI: binding [mmole/mole Hb]/dose [mmole/kgl) and the ratios of hydrolyzable adducts were determined. The HBI ranged between <0.02
and 69.0. The results indicate the in vivo formation of several, covalently bound, hydrolyzable hemoglobin adducts. Conclusions on prevailing meta-
bolic pathways can be drawn. Total binding of several compounds seems sufficient for biomonitoring of human blood samples. These chemicals are
considered representative for environmental contamination with explosives of this type, and we propose their Hb adducts be used as dosimeters
for human exposure to these suspected carcinogens. - Environ Health Perspect 102(Suppl 6):43-45 (1994)
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Introduction
Polyfunctional, monocyclic amino- and
nitroarenes are widespread intermediates in
chemical industries. They have recently
attracted attention as soil contaminants in
areas of former production and use of
explosives (1). Many of them were found
mutagenic and carcinogenic in appropriate
test systems, and may also be hazardous for
humans ifabsorbed and metabolically acti-
vated (2).
In vivo metabolism comprises reduction
of nitro groups and oxidation of amino
groups, resulting in N-nitroso intermediates
that bind to the SH-group of cysteine in
hemoglobin (Figure 1) (3). The resulting
sulfinamide can be hydrolyzed, which yields
one or more cleavage products. These can be
extracted and analyzed with high sensitivity
by HPLC/ECD. In case of polyfunctional
derivatives, multiple cleavage products can
result, depending on the metabolic reactions
that have occurred with the nonbinding
substituent. The measurement ofhemoglobin
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wmoglobin nitrotoluene, and 2-nitro-4-aminotoluene
cperiments from Aldrich. Samples of 2-amino-4,6-
lentified. dinitrotoluene and 4-amino-2,6-dinitro-
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iotoluene, nische Untersuchungen in Swistal,
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were dissolved in 200 to 250 pl 1,2-
propanediol, 1,2-propanediol and ethanol
(70/30), or tricaprylin and administered by
gavage to three animals per compound.
Blood was obtained after 24 hr by heart
puncture under ether anesthesia with a
s-Hb heparinized syringe. Bloodwas centrifuged at
2000g for 5 min, and red blood cells were
washed three timeswith 0.9% NaClsolution.
After lysis of the cells in 4 vol EDTA
(10-4M, pH 7.5), and centrifugation at
lobin adducts 4000g for 5 min, hemoglobin was precipi-
ntermediates tated from the supernatant by dropwise
ion of amino addition of4 vol ethanol while stirring. The
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Table 1. Type of substitution ofthe test compounds, total amount of hydrolyzable adducts, hemoglobin-binding
indices (HBI).a
Toluenes Benzenes
Functional group Substitution HBI Substitution HBI
Trinitro- 2,4,6 6.0 ± 2.0
Dinitro- 2,6 1.2 ± 0.4
2,4 0.7 ± 0.4 1,3 69.0 ± 40.8
Aminonitro- 4,2 0.1 ± 0.01
2,4 1.0 ±0.4 1,3 3.1 ±0.9
Diamino- 2,6 0.15± 0.08
2,4 <0.02 1,3 0.7±0.13
an=3; mean±SD. bn=2.
Table2. Thetest compounds and thecomposition ofthe products obtained by hydrolysis ofthe
hemoglobin adducts.
Test compound Cleavage product Fraction, %
2,4,6-Trinitrotoluene 4-Amino-2,6-dinitrotoluene 100
2,6-Dinitrotoluene 2-Amino-6-nitrotoluene 84
2,6-Diaminotoluene 16
2,4-Dinitrotoluene 2-Nitro-4-aminotoluene 100
2-Amino-4-nitrotoluene 2,4-Diaminotoluene 90
2-Acetylamino-4-aminotoluene 10
4-Amino-2-nitrotoluene 4-Amino-2-nitrotoluene 100
2,6-Diaminotoluene 2-Acetylamino-6-aminotoluene 100
2,4-Diaminotoluene Not detectable
1,3-Dinitrobenzene 1-Amino-3-nitrobenzene 81
1-Acetylamino-3-aminobenzene 13
1,3-Diaminobenzene 6
1-Amino-3-nitrobenzene 1-Amino-3-nitrobenzene 62
1-Acetylamino-3-aminobenzene 23
1,3-Diaminobenzene 15
1,3-Diaminobenzene 1-Acetylamino-3-aminobenzene 90
1,3-Diaminobenzene 10
10,000g. Precipitated hemoglobin was
washed with ethanol and water (80/20),
ethanol (96%), ethanol and ether (25/75),
and ether, dried over silica in a desiccator,
and stored at-180C.
For adduct analysis, 10 to 50 mg hemo-
globin was hydrolyzed using structurally
similar recovery standards in a solution of
0.3 ml 0.5% SDS, 3 ml aqua bidest, and
0.3 ml 10 N NaOH (alkaline hydrolysis)
or 3 ml 10% H3PO4 (acidic hydrolysis).
The mixture was stirred for 1 hr at room
temperature. After centrifugation and solid
phase extraction (Polysorb MP-1 columns,
100 mg, Interaction Chemicals Inc., or
Bond elut SCX-columns, 100 mg,
Analytichem International, after acidic
hydrolysis), an internal standard (Anilin, 1-
amino-4-nitrobenzene) was added, and the
extract was concentrated under a stream of
N2. Recovery was determined with hemo-
globin from untreated control animals by
addition ofstandard solutions, under iden-
tical conditions.
The samples were analyzed by
HPLC/ECD using a Waters model 590
HPLC pump with a Rheodyne injector
(model 7125). The electrochemical detector
(ESA model 5100 A) was equipped with an
analytical cell (model 5011), and was oper-
ated at potentials of0.6 to 0.85 V. The fol-
lowing columns were used: LiChrospher
60 RP-select B, 5 jim, 250 x 4 mm
(Merck); Superspher 60 RP-8, 4 pm, 250 x
4 mm (Merck); Cyclobond 1, 5 pm, 250 x
4 mm (Astec); or Zorbax ODS, 5 pm, 250
x 4 mm (Bischoff). Precolumns, 20 x 2
mm (GAT-Analysentechnik) were filled
with Perisorb, 20 to 40 pm (Merck).
Sodium phosphate buffers (0.02 M, pH
2.3-5.8) with varying amounts of acetoni-
trile and methanol were used as eluents.
Chromatograms were quantified by com-
parison with external standard solutions
(Figure 2) using an Epson AX3s computer
and integration software from PE Nelson
(Cupertino, CA). The total amount of
hydrolyzable adducts was calculated as
hemoglobin binding index (HBI: binding
[mmole/mole Hb]/dose [mmole/kg]).
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Figure 2. HPLC/ECD chromatogram of the standard
mixture (A) and of the cleavage products extracted
after hydrolysis of hemoglobin from an animal, treated
with 2,4-dinitrotoluene (B). In this case, 4-nitroaniline
and 2-amino-6-nitrotoluene were added as internal and
recovery standards, respectively.
Results
After a single oral dose of the amino- and
nitroarenes to female Wistar rats, all test
compounds except one formed adducts
that could be hydrolyzed from hemoglobin
preparations under mild acidic or alkaline
conditions. The exception was 2,4-
diaminotoluene. The detection limit was in
the range of 10 to 50 ng/g Hb for each
cleavage product. Recovery of the sub-
stances was between 36 and 82%. None or
extremely small amounts of the cleavage
products were detected in control experi-
ments in which hemoglobin was treated
under neutral, but otherwise unchanged,
conditions.
Animals treated with 1,3-dinitroben-
zene developed visible met-hemoglobinemia
(met-Hb) with the dose that was adminis-
tered. One of them died after a few hours.
These observations are in line with the
known potency ofthis compound for met-
Hb formation and its extent ofhemoglobin
binding. The HBIs of the two surviving
animals were 98 and 40, respectively.
However, the dose of 1,3-dinitrobenzene
(0.5 mmole/kg) corresponded to the
median lethal dose reported by Cody et al.
(7) as 83 mg/kg (0.53 mmole/kg).
In general, toluene derivatives bind less
extensively to hemoglobin than the corre-
spondingly substituted benzenes. The total
amount of hydrolyzable adducts varied
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within a wide range; this is given in Table
1 as the HBI. Up to three cleavage prod-
ucts were detected, but one dominated in
all cases. A specific pattern ofhydrolyzable
adducts was obtained for each chemical.
The identified cleavage products and the
percentage of the hydrolyzable and identi-
fied adducts are listed in Table 2. The
identification is based on HPLC cochro-
matography with authentic reference com-
pounds under different conditions. Major
cleavage products were also analyzed by
GC-MS.
Discussion
Because metabolites that bind covalently to
the SH-group of cysteine in hemoglobin
are nitroso derivatives (3,8), our results
demonstrate that such metabolites are
formed either by in vivo reduction of a
nitro group or by oxidation of an amino
group. The chemical structure ofthe parent
compounds apparently influences the
metabolism in each case in a specific way,
and thus determines the bioavailability of
the reactive intermediate. With many ofthe
compounds tested, N-acetylated adducts
were formed. However, the ratio of acety-
lated to nonacetylated cleavage products
was quite variable, which again indicates
specific pharmacokinetics for each sub-
stance. No hydrolyzable adduct above the
detection limit was obtained with 2,4-
diaminotoluene. This is probably because
of more extensive C-oxidation, including
that ofthe methyl group.
The total amount and pattern ofcleavage
products permits the following conclu-
sions: first, reduction of nitro groups
exceeds N-oxidation of amino groups, as
indicated by adduct formation. The low
levels of hemoglobin binding by diamino-
substituted compounds may result from
moderate amine oxidation or low bioavail-
ability ofthe reactive metabolites. In addi-
tion, with nitroarenes nitroso-intermediates
are likely to be formed by reduction of a
nitro group rather than the reoxidation of
an amino group after complete reduction.
Second, addition ofa methyl group lowers
adduct formation, nitro substituents in
para-position to the methyl group of
toluene derivatives are preferably reduced.
Third, alternate pathways such as C-oxida-
tion, ring hydroxylation, and possibly
quinone-imine generation also may be
important metabolic pathways. Production
of nonhydrolyzable adducts or more rapid
elimination of detoxification products
could be the reason for unexpected low
hemoglobin-binding indices in some cases.
The compounds 2,4,6-trinitrotoluene,
2,4- and 2,6-dinitrotoluene, 2-amino-4-
nitrotoluene, and 2,4-diaminotoluene are
classified as carcinogenic in experimental
animals. 1,3-Diaminobenzene and 1,3-
dinitrobenzene are suspected ofhaving car-
cinogenic potential (2). This group of
substances is therefore considered haz-
ardous for exposed populations.
Soil in certain areas of former explosives
production may contain rather large amounts
ofnitroarenes (1). The actual uptake by dif-
ferent possible routes by people living or
working or both in these areas is difficult to
assess but should be measured as a basis for
risk assessment. We propose to use the major
hemoglobin adducts of2,4,6-trinitrotoluene,
2,6-dinitrotoluene, and 1,3-dinitrobenzene as
dosimeters for exposure in biomonitoring of
potentiallyexposed populations.
Simple correlations between hemoglobin
binding and carcinogenicity of this group
ofcompounds could not be detected. More
information is needed to understand better
the complex pharmacokinetics of these
chemicals and eventually to proceed from
exposure control to risk assessment.
REFERENCES
1. Haas R, Schreiber I, Stork G. Ru'stungsaltlasten Z. Umweltchem.
Okotox 2:139-141 (1990).
2. Henschler D (ed). Gesundheitsschadliche Arbeitsstoffe, Toxikologisch-
arbeitsmedizinische Begriindung von MAK-Werten (Maximale
Arbeitsplatz-Konzentrationen), Weinheim, Deutschland: VCH
Verlagsgellschaft mbH (1985-1988).
3. Neumann H-G, Metzler M, Topner W. Metabolic activation of
diethylstilbestrol and aminostilben-derivatives. Arch Toxicol 39:21-30
(1977).
4. Ehrenberg L, Ostermann-Golkar S, Segerback D, Svenson K,
Callemann CJ. Evaluation of genetic risks of alkylating agents III.
Alkylation ofhemoglobin after metabolic conversion of ethene oxide
in vivo. Mutat Res 45:175-184 (1977).
5. Ostermann-Golkar S, Ehrenberg L, Segerback D, Hallstrom I.
Evaluation of genetic risks of alkylating agents II. Hemoglobin as a
dose monitor. Mutat Res 34:1-10 (1976).
6. WielandE, NeumannH-G.Methemoglobin formation and binding to
blood constituents as indicators for the formation, availability and reac-
tivity ofactivated metabolites from trans-4-aminostilbene and related
aromatic amines. Arch Toxicol 40:17-35 (1978).
7. Cody T, Witherup S, Hastings L, Stemmer K, Christian RT. 1,3-
Dinitrobenzene: toxic effects in vivo and in vitro. J Toxicol Environ
Health 7:829-847 (1981).
8. D6lle B, T6pner W, Neumann H-G. Reaction of aryl-nitroso com-
pounds with mercaptans. Xenobiotica 10:527-536 (1980).
Volume 102, Supplement 6, October 1994 45